Kenvue’s Next Big Test: Can Tylenol And ZYRTEC Strength Offset Broader Weakness?
Kenvue's second quarter of 2025 reflected ongoing challenges amid strategic transitions and shifting market dynamics. The company reported a 4.2%...
97 Views
Primer: Kenvue (KVUE US) - Aug 2026
Iconic Brand Portfolio Drives Competitive Advantage: Kenvue stands as the world's largest pure-play consumer health company by revenue, built...
95 Views
Kenvue Tylenol Lawsuits Return—Could They Threaten Kimberly-Clark’s $48.7 Billion Deal?
Kenvue is facing a renewed legal overhang just as Kimberly-Clark works toward completing its $48.7 billion acquisition. On July 13, a federal...
130 Views
Weekly Update (MRP, WDC, HON, LGFA)
Honeywell International (HON) announced its plan to spin off its Advanced Materials business on October 8, 2024. Subsequently, on February 6, 2025,...
401 Views
Weekly Update: January 10, 2025
Galapagos NV (GLPG), a Belgian biotechnology company, announced on January 8, 2025, its plan to split into two publicly traded entities by mid-2025.
574 Views